Abstract
Bisphosphonates have been widely used in the treatment of osteoporosis in women, whereas until now there have been few data on their use in men. The aim of this study was to evaluate the effect of a 3-year alendronate treatment on bone mineral density (BMD) and quantitative ultrasound (QUS) in men with primary osteoporosis. We studied 77 osteoporotic men (aged 57.1 ± 10.8 yrs) who completed a 3-year treatment with alendronate (10 mg/day) plus calcium (1000 mg/day) (n = 39), or calcium alone (n = 38). At baseline and at a 12-month interval, we measured BMD at the lumbar spine and femur (femoral neck and total hip) by DXA (Hologic) and speed of sound (SOS), broadband ultrasound attenuation (BUA) and Stiffness (S) at the os calcis by Achilles plus (Lunar). Alendronate treatment had significantly increased lumbar spine BMD by 4.2% at year 1, by 6.3% at year 2, and 8.8% at year 3. BMD at the femoral neck and total hip had increased by 2.1% and 1.6% at year 1, by 3.2% and 2.9% at year 2, and by 4.2% and 3.9% at year 3, respectively. BUA and Stiffness showed a significant increase in the alendronate-treated group at year 2 (3.2% and 4.9%, respectively) and at year 3 (3.8% and 6%, respectively). BMD at the lumbar spine showed the best longitudinal sensitivity whereas longitudinal sensitivity of both QUS at the heel and femur BMD were similar. In conclusion, this study confirms that alendronate represents an important therapeutic advance in the management of male osteoporosis. BMD at the lumbar spine appears to be the best method for monitoring the effect of alendronate on bone mass in osteoporotic men.
Similar content being viewed by others
References
LJ Melton III (2001) ArticleTitleThe prevalence of osteoporosis: gender and racial comparison. Calcif Tissue Int 69 179–181 Occurrence Handle10.1007/s00223-001-1043-9 Occurrence Handle11730244
E Seeman (1999) ArticleTitleOsteoporosis in men. Osteoporos Int (suppl) 2 S97–S110
C Cooper G Campion LJ Melton III (1992) ArticleTitleHip fractures in the elderly: a world-wide projection. Osteoporos Int 2 285–289 Occurrence Handle1:STN:280:ByyD2czovVE%3D Occurrence Handle1421796
ES Orwoll (1998) ArticleTitleOsteoporosis in men. Osteoporos Int 27 349–367 Occurrence Handle1:STN:280:DyaK1czjtlOnuw%3D%3D
TW O’Neill D Felsenberg J Varlow C Cooper JA Kanis AJ Silman (1996) ArticleTitleThe prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study. J Bone Miner Res 11 1010–1018 Occurrence Handle8797123
JR Center TV Nguyen D Schneider PN Sambrook JA Eisman (1999) ArticleTitleMortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353 878–882 Occurrence Handle1:STN:280:DyaK1M7ptFOlug%3D%3D Occurrence Handle10093980
L Katznelson JS Finkelstein DA Schoenfeld DI Rosenthal EJ Anderson A Klibanski (1996) ArticleTitleIncrease in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 12 43–58
PJ Snyder H Peachey JA Berlin P Hannoush G Hadda A Dlewati J Santanna I Loh DA Lenrow JH Olmes SC Kapoor LE Atkinson BL Strom (1999) ArticleTitleEffect of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 84 1966–1972 Occurrence Handle1:CAS:528:DyaK1MXjs1Ohsr4%3D Occurrence Handle10372695
E Orwoll M Ettinger S Weiss P Miller D Kendler J Graham S Adami K Weber R Lorene P Pietschmann K Vandormacl A Lombardi (2000) ArticleTitleAlendronate for the treatment of osteoporosis in men. N Engl J Med 343 604–610 Occurrence Handle1:CAS:528:DC%2BD3cXmsFSqs7k%3D Occurrence Handle10979796
YV Ho AG Frauman W Thomson E Seeman (2000) ArticleTitleEffects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 11 98–101 Occurrence Handle1:CAS:528:DC%2BD3cXjs1Wmt78%3D Occurrence Handle10793867
JD Ringe H Faber A Dorst (2001) ArticleTitleAlendronate treatment of established primary osteoporosis in men: results of a two-year prospective study. J Clin Endocrinol Metab 86 5252–5255 Occurrence Handle1:CAS:528:DC%2BD3MXos1Kqs7c%3D Occurrence Handle11701687
T Weber M Drezner (2001) ArticleTitleEffect of alendronate on bone mineral density in male idiopathic osteoporosis. Metabolism 50 912–915 Occurrence Handle10.1053/meta.2001.24925 Occurrence Handle1:CAS:528:DC%2BD3MXlvVClu7Y%3D Occurrence Handle11474478
UA Liberman SR Weiss J Broll HW Minnie H Quan NH Bell J Rodriguez-Portales RW Downs Jr J Dequecker M Favus (1995) ArticleTitleEffect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333 1437–1443 Occurrence Handle1:CAS:528:DyaK28XkslehtA%3D%3D Occurrence Handle7477143
DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud (1996) ArticleTitleRandomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348 1535–1541 Occurrence Handle1:CAS:528:DyaK2sXisFCktQ%3D%3D Occurrence Handle8950879
B Cortet P Dubois N Boutry G Palos A Cotton X Marchandise (2002) ArticleTitleComputed tomography image analysis of the calcaneous in male osteoporosis. Osteoporos Int 13 33–41 Occurrence Handle10.1007/s198-002-8335-4
E Legrand D Chappard C Pascaretti M Duquenne C Rondeau Y Simon V Rohmer M.F. Basle M Audran (1999) ArticleTitleBone mineral density and vertebral fractures in men. Osteoporos Int 10 265–270 Occurrence Handle10.1007/s001980050225 Occurrence Handle1:STN:280:DC%2BD3c7lslelsA%3D%3D Occurrence Handle10692973
CC Gluer (1997) ArticleTitleQuantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 12 1280–1288 Occurrence Handle9258759
CC Gluer CY Wu M Jergas SA Goldstein HK Genant (1994) ArticleTitleThree quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int 55 46–52 Occurrence Handle7922789
CF Njeh T Fuerst E Diessel HK Genant (2001) ArticleTitleIs quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int 12 1–15 Occurrence Handle10.1007/s001980170151 Occurrence Handle1:STN:280:DC%2BD3M3ivFKhsQ%3D%3D Occurrence Handle11305077
D Hans P Dargent-Molina AM Schott JL Sebert C Cormier PO Kotzki PD Delmas JM Pouilles G Breart PG Meunier (1996) ArticleTitleUltrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348 511–514 Occurrence Handle1:STN:280:BymA2cjnvVU%3D Occurrence Handle8757153
DC Bauer CC Gluer JA Cauley TM Vogt KE Ensrud HK Genant DM Blake (1997) ArticleTitleBroadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. Arch Intern Med 157 629–634 Occurrence Handle1:STN:280:ByiB3srpvFw%3D Occurrence Handle9080917
O Sahota P San SA Cawte D Pearson DJ Hosking (2000) ArticleTitleA comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy. Osteoporos Int 11 52–58 Occurrence Handle10.1007/s001980050006 Occurrence Handle1:CAS:528:DC%2BD3cXhvFGgsrw%3D Occurrence Handle10663359
S Gonnelli C Cepollaro A Montagnani S Martini L Gennari M Mangeri C Gennari (2002) ArticleTitleHeel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int 13 415–421 Occurrence Handle10.1007/s001980200048
MA Krieg AF Jacquet M Bremgartner S Cuttelod D Thiebaud P Burckardt (1999) ArticleTitleEffect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporos Int 9 483–488 Occurrence Handle10.1007/s001980050174 Occurrence Handle1:CAS:528:DyaK1MXlslSltrw%3D Occurrence Handle10624454
W Pluskiewicz B Drozdzowska (1999) ArticleTitleUltrasound measurements at the calcaneus in men: differences between healthy and fractured persons and the influence of age and anthropometric features on ultrasound parameters. Osteoporos Int 10 47–51 Occurrence Handle10.1007/s001980050193 Occurrence Handle1:STN:280:DyaK1MvjtFKhsg%3D%3D Occurrence Handle10501779
RA Adler HL Funkhouser CM Holt (2001) ArticleTitleUtility of heel ultrasound bone density in men. J Clin Densitom 3 225–230
A Montagnani S Gonnelli C Cepollaro M Mangeri R Monaco L Gennari C Gennari (2001) ArticleTitleUsefulness of bone quantitative ultrasound in management of osteoporosis in men. J Clin Densitom 3 231–237
D Mulleman I Legroux-Gerot B Duquesnoy X Marchandies B Delcambre B Cortet (2002) ArticleTitleQuantitative ultrasound in bone male osteoporosis. Osteoporos Int 13 388–393 Occurrence Handle10.1007/s001980200044
CC Gluer (1999) ArticleTitleMonitoring skeletal changes by radiological techniques. J Bone Miner Res 14 1952–1962 Occurrence Handle10571696
JR Tucci RP Tonino RD Emkey CA Peverly U Kher AC Santora II (1996) ArticleTitleEffect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101 488–501 Occurrence Handle10.1016/S0002-9343(96)00282-3 Occurrence Handle1:CAS:528:DyaK28XnsFOmsrg%3D Occurrence Handle8948272
AM Parfitt (1980) ArticleTitleMorphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab 4 273–287
J Hanson (1997) ArticleTitleStandardization of femur BMD (letter). J Bone Miner Res 12 1316–1317 Occurrence Handle1:STN:280:ByiH3czjvFE%3D Occurrence Handle9258764
R Patel GM Blake J Rymer I Fogelman (2000) ArticleTitleLong-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 11 68–75 Occurrence Handle10.1007/s001980050008 Occurrence Handle1:STN:280:DC%2BD3c7ivFKqtA%3D%3D Occurrence Handle10663361
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gonnelli, S., Cepollaro, C., Montagnani, A. et al. Alendronate Treatment in Men With Primary Osteoporosis: A Three-Year Longitudinal Study . Calcif Tissue Int 73, 133–139 (2003). https://doi.org/10.1007/s00223-002-1085-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-002-1085-7